Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics

References

Page 1

	Year	Citations
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology Sue Richards, Nazneen Aziz, Sherri J. Bale, Genetics in Medicine Allelic VariantSequence VariantsMedicineGeneticsAmerican College	2015	30.5K
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing Robert C. Green, Jonathan S. Berg, Wayne W. Grody, Genetics in Medicine Next-generation SequencingAcmg RecommendationsDiagnosisPathologyPersonal Genomics	2013	2.5K
ClinGen — The Clinical Genome Resource Heidi L. Rehm, Jonathan S. Berg, Lisa Brooks, New England Journal of Medicine Clinical Genome ResourceGenetic TestingFamily MembersCardiometabolic RiskGenetics	2015	1.5K
Diagnosis and treatment of Wilson disease: An update Eve A. Roberts, Michael L. Schilsky Hepatology Clinical DisordersClinical FindingPathologyWilson DiseaseNeuropathology	2008	1.3K
Mutations in Myosin Light Chain Kinase Cause Familial Aortic Dissections Li Wang, Dongchuan Guo, Jiumei Cao, The American Journal of Human Genetics Aortic DiseasesPathologyMedicineCell BiologyAortic Dissection	2010	311
Anticipate and Communicate: Ethical Management of Incidental and Secondary Findings in the Clinical, Research, and Direct-to-Consumer Contexts (December 2013 Report of the Presidential Commission for the Study of Bioethical Issues) Charles S. Weiner American Journal of Epidemiology Ethical ManagementBiomedical EthicGenetic EpidemiologyLawBioethical Issues	2014	301
A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation Jessica Ezzell Hunter, Stephanie A. Irving, Leslie G. Biesecker, Genetics in Medicine	2016	146
Utility of whole-genome sequencing for detection of newborn screening disorders in a population cohort of 1,696 neonates Dale L. Bodian, Elisabeth Klein, Ramaswamy K. Iyer, Genetics in Medicine	2015	133
Risk of serious illness in heterozygotes for ornithine transcarbamylase deficency Mark L. Batshaw, Michael E. Msall, Arthur L. Beaudet, The Journal of Pediatrics MedicineInherited Metabolic DiseasePathologyToxicologyMetabolomics	1986	130
A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencing Jonathan S. Berg, Ann Katherine M. Foreman, Julianne O’Daniel, Genetics in Medicine	2015	98

Page 1